The Israeli MOH is hiding a study it conducted, showing a 2-4 times higher rate of adverse events reports following Pfizer COVID vaccine in kids aged 5-11 vs ages 12-17.
The study, commissioned by the MOH, also indicates new adverse events not reported in Pfizer’s leaflet, and that some adverse events last more than a year. Despite being aware of these findings, the MOH is hiding them from the public and has recently authorized the booster dose for ages 5-11 and is preparing to approve the vaccine for infants.
The findings show, among other things, that adverse events are 2-4 times more common among young children aged 5-11; that there are new adverse events that have not been reported in Pfizer’s COVID vaccine leaflet; that contrary to what has been claimed, various adverse events, including neurological effects and menstrual disorders, are not short-term events that pass within a few days, but in many cases, they last for months or even more than a year. Moreover, the study found that a significant proportion of the symptoms did not disappear by the end of the study, so it is not possible to know how long they lasted; and a considerable part of the cases even if the adverse event ceased, it recurred after the next dose.
During the study period, 8,054 reports of vaccine-related adverse events were received in all age groups (5-11; 12-17; 18 and over), of which 6,259 were defined as “valid” (without duplication or empty reports ). In addition, 2,075 adverse events were reported as free text. Of the reports submitted as free text – five categories together constitute about 70% of all reported adverse events. These categories were analyzed by the research team, and include (in order of frequency):
1. Neurological effects;
2. General effects (not included in any of the categories specifically);
3. Menstrual disorders;
4. Symptoms in the musculoskeletal system;
5. Symptoms in the gastrointestinal tract/kidneys and urinary tract.
Cardiovascular symptoms were noted in the sixth category, with slightly fewer reports compared to the fifth category. However, this category was not analyzed by the team, although it was precisely these adverse events, such as myocarditis and pericarditis, that were found to be related to the vaccine and common among teenagers and young adults. Also, according to the team members who presented the study, there are other symptoms such as autoimmune symptoms, which are important to analyze in order to better identify the safety profile of the vaccine, but at this stage have not been analyzed.
Full story here.